Issue |
Section |
Title |
File |
Vol 72, No 2 (2017) |
HEALTH CARE MANAGEMENT: CURRENT ISSUES |
AUTOMATED DOCUMENT MANAGEMENT SYSTEM OF PHARMACEUTICAL MANUFACTURER’S QUALITY MANAGEMENT SYSTEM IN ACCORDANCE WITH REQUIREMENTS OF GMP |
(Rus)
|
Vol 73, No 3 (2018) |
HEALTH CARE MANAGEMENT: CURRENT ISSUES |
CHANGE MANAGEMENT OF DRUG PRODUCTS REGISTRATION CONDITIONS: NEW ICH Q12 GUIDELINE |
(Rus)
|
Vol 73, No 6 (2018) |
NEUROLOGY AND NEUROSURGERY: CURRENT ISSUES |
Perspective Nerve Conduits for Stimulation of Regeneration of Damaged Peripheral Nerves |
(Rus)
|
Vol 75, No 1 (2020) |
OBSTETRICS AND GYNAECOLOGY: CURRENT ISSUES |
Possibilities of application of regenerative technologies in gynecology |
(Rus)
|
Vol 75, No 3 (2020) |
NEUROLOGY AND NEUROSURGERY: CURRENT ISSUES |
C-fos, ERK1/2, MAP2, NOTCH1 Proteins Expression Patterns in Human Cerebral Cortex Neurons after Ischemic Stroke |
(Rus)
|
Vol 76, No 4 (2021) |
INFECTIOUS DISEASES: CURRENT ISSUES |
Modern Tendencies of the Use and Development of Drugs of Bacteriophages |
(Rus)
|
Vol 77, No 3 (2022) |
INFECTIOUS DISEASES: CURRENT ISSUES |
COVID-19 in Russia: Evolution of Views on the Pandemic. Report I |
(Rus)
|
Vol 77, No 4 (2022) |
EPIDEMIOLOGY: CURRENT ISSUES |
COVID-19 in Russia: Evolution of Views on the Pandemic. Report II |
(Rus)
|
Vol 78, No 3 (2023) |
PHARMACOLOGY: CURRENT ISSUES |
Comprehensive Assessment of Technological Readiness of an Innovative Project during the Development of a Pharmaceutical Product |
(Rus)
|
Vol 79, No 3 (2024) |
PHARMACOLOGY: CURRENT ISSUES |
The Role of Artificial Intelligence in Reducing the Risk of Adverse Reactions in Multiple Drug Interactions |
|
Vol 79, No 1 (2024) |
INFECTIOUS DISEASES: CURRENT ISSUES |
Analysis of the Risk of COVID-19 in the Post-Vaccination Period Based on the Results of a Multicenter Study — a Survey of Medical Workers |
|
Vol 78, No 6 (2023) |
CARDIOLOGY AND CARDIOVASCULAR SURGERY: CURRENT ISSUES |
Drug Interactions in the Treatment of Chronic Heart Failure: Analysis of Clinical Guidelines |
|
Vol 79, No 4 (2024) |
PHARMACOLOGY: CURRENT ISSUES |
Polypharmacotherapy: the Use of Artificial Intelligence to Reduce Risk of Adverse Drug Reactions (Review) |
|